Squamous Intraepithelial Lesions of the Cervix: Clinical Trials

5 trials for Squamous Intraepithelial Lesions of the Cervix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 enrolling by invitation, 1 not yet recruiting. 1 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Not yet recruiting 1
Phase 41Recruiting 1

Follow Squamous Intraepithelial Lesions of the Cervix: new trials by email Literature Review of Squamous Intraepithelial Lesions of the Cervix trials Research Report on Squamous Intraepithelial Lesions of the Cervix

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV
Nonavalent HPV vaccine (9vHPV) - HPV, High-risk HPV (Any Strain)
Phase 2Not yet recruitingInstitut d'Investigació Biomèdica de Bellvitge802026-02-012026-02-11
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)
Nonavalent HPV vaccine (9vHPV/Gardasil-9™). - Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections
Phase 4RecruitingMiquel Angel Pavon Ribas692022-09-132026-02-23
Conservative Management of HSIL in Patients With Future Pregnancy Aspiration
Conservative management with regular follow-up, Conization - Cervical Intraepithelial Neoplasia, Squamous Intraepithelial Lesions of the Cervix
RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2002021-03-032021-03-05
Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance
PAPILOCARE - Squamous Intraepithelial Lesions of the Cervix, Human Papilloma Virus Infection
Not applicableCompletedCentre Hospitalier Régional d'Orléans812020-11-172023-06-15
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies
GeneTherapy - Cervical Intraepithelial Neoplasia, Cervical Neoplasms
Enrolling by invitationNational Cancer Institute (NCI)10002020-05-082026-10-02

Narrower conditions

Papillomavirus Infections (3)  ·  Uterine Cervical Neoplasms (3)  ·  Infections (2)  ·  Uterine Cervical Dysplasia (2)  ·  Oropharyngeal Neoplasms (1)

Broader conditions

Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Genital Diseases (5)  ·  Genital Diseases, Female (5)  ·  Morphological and Microscopic Findings (5)  ·  Neoplasms (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Precancerous Conditions (5)  ·  Squamous Intraepithelial Lesions (5)  ·  Urogenital Diseases (5)  ·  Uterine Cervical Diseases (5)  ·  Uterine Diseases (5)  ·  Communicable Diseases (3)  ·  DNA Virus Infections (3)  ·  Disease Attributes (3)

Interventions

Conization (1)

Sponsors

Centre Hospitalier Régional d'Orléans (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Institut d'Investigació Biomèdica de Bellvitge (1)  ·  Miquel Angel Pavon Ribas (1)  ·  National Cancer Institute (NCI) (1)

Countries

Spain (2)  ·  France (1)  ·  Sierra Leone (1)  ·  United States (1)

Top investigators

Cristina Vanrell Barbat, MD (1)  ·  Nerea Nerea (1)  ·  Scott M Norberg, D.O. (1)

Results publications

PMID 18630456, PMID 38768231